Amarin Corp Plcuk (AMRN) Total Debt (QoQ) (2011 - 2020)
Amarin Corp Plcuk (AMRN) Total Debt (QoQ) (2011 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -57.77% |
| Jun 30, 2020 | -39.27% |
| Mar 31, 2020 | -26.24% |
| Dec 31, 2019 | 66.26% |
| Sep 30, 2019 | -12.49% |
| Jun 30, 2019 | -7.65% |
| Mar 31, 2019 | -7.53% |
| Dec 31, 2018 | -4.41% |
| Sep 30, 2018 | -3.87% |
| Jun 30, 2018 | -2.68% |
| Mar 31, 2018 | -3.58% |
| Dec 31, 2017 | -2.69% |
| Sep 30, 2017 | -2.41% |
| Jun 30, 2017 | -1.30% |
| Mar 31, 2017 | -1.67% |
| Dec 31, 2016 | 561.95% |
| Sep 30, 2016 | -90.24% |
| Jun 30, 2016 | 3.32% |
| Mar 31, 2016 | 1.49% |
| Dec 31, 2015 | 6.50% |